SCHEMBL4294468

SCHEMBL4294468

O=C(O)N(Cc1ccccc1)C1C2CNCC21

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.60
MC4R P32245 2/20 0.46
SSTR4 P31391 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 2/20 0.41
AGER Q15109 3/20 0.40
MTNR1A P48039 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM3 P20309 1/20 0.40
HTR2C P28335 1/20 0.40
OPRM1 P35372 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
GBA1 P04062 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3617810 0.83 CTSD (0.48) CTSDSSTR4SLC6A4HTR2CCA12
SCHEMBL1814533 0.80 SLC6A2 (0.51) CTSDMC4RSSTR4SLC6A2SLC6A4
SCHEMBL14741312 0.80 SLC6A2 (0.51) CTSDMC4RSSTR4SLC6A2SLC6A4
SCHEMBL7867639 0.80 SLC6A2 (0.51) CTSDMC4RSSTR4SLC6A2SLC6A4
SCHEMBL14087065 0.80 SLC6A2 (0.51) CTSDMC4RSSTR4SLC6A2SLC6A4
SCHEMBL2421731 0.79 CTSD (0.56) CTSDMC4RSSTR4MEN1KMT2A
SCHEMBL2534991 0.78 CTSD (0.68) CTSDMC4RMEN1KMT2ASLC6A2
SCHEMBL3880578 0.78 CTSD (0.68) CTSDMC4RMEN1KMT2ASLC6A2
SCHEMBL2534993 0.78 CTSD (0.68) CTSDMC4RMEN1KMT2ASLC6A2
SCHEMBL14741345 0.77 CHRM2 (0.47) CTSDSSTR4SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071592-B2 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones GLAXO GROUP LIMITED (GB) 2011-12-06 US disclosed
US-20090270374-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES GLAXO GROUP LIMITED (GB) 2009-10-29 US disclosed
EP-1992628-A1 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones GLAXO GROUP LIMITED (GB) 2008-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270374-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES ETFA, NQO2, GNAQ CTSD 1759/4885MC4R 4138/4885SSTR4 4254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.